Organon & Co.
OGNNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$3.627 B
$13.81 -0.14%
Close of 6 Nov 2026
As of 6 Nov 2026, Organon & Co. (OGN) has a market capitalization of $3.63B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$6.22B
#575 by revenue
Earnings
$187.0M
#1027 by earnings
Shares outstanding
262,621,584
Latest filing cover page
P/E ratio
19.4
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #61Xenon PharmaceuticalsXENE$3.66B
- #62Acadia PharmaceuticalsACAD$3.65B
- #63Organon & Co.OGN$3.63B
- #64AbCellera BiologicsABCL$3.60B
- #65Tango TherapeuticsTNGX$3.52B
What if Organon & Co. were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Organon & Co. are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.